Inositol for Bipolar Disorder

"Presently, there are 7 scientific investigations into the efficacy of Inositol. Of those trials, 1 is in its final phase. These studies span across 7 sites with a concentration in Boston Massachusetts."

"Prospective participants of this clinical trial should present with anxiety disorders and fall within the 8-17 age range. This is a limited recruitment, expecting no more than 20 enrollees."

"As seen on clinicaltrials.gov, the enrolment for this trial is currently paused; it was first posted on November 1, 2022 and has been modified most recently as of November 4th, 2022. Despite its temporary suspension in recruitment, 1512 other studies are actively searching for individuals to take part in them."

"At the present moment, this trial has ceased to accept new participants. Initially posted on November 1st 2022 and last updated four days later, these openings have filled up. Nonetheless, those hoping for an alternative should be aware that there are 1505 clinical trials related to anxiety disorders actively recruiting patients as well as 7 studies involving Inositol still accepting applicants."

"To be considered for enrollment, participants must fall into the 8 to 17 year-old age bracket. Currently, there are 372 clinical trials specifically tailored towards minors and 1033 studies targeting seniors."

"During Weeks 1-14, this trial will primarily assess the safety and tolerability of myo-inositol through changes in patients' physical symptom checklist. The efficacy of myo-inositol for treating anxiety symptoms is measured with three different assessments: Brief Child Mania Rating Scale Parent Version (BCMRS-P), Self Report for Childhood Related Emotional Disorders (SCARED) and Clinical Global Impression Severity (CGI-S). Each assessment utilizes a Likert type scale to score from 0 - 30, 82 or 7 respectively; depending on which evaluation tool is utilized."